Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access

British Journal of Surgery

Volumn 96, Issue 1, 2009, Pages 34-39

  Chemla, E S ^a   Morsy, M ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CATHETERS, INDWELLING; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PILOT PROJECTS; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME; URETER;

EID: 58149485034     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6434     Document Type: Article

References (24)

1. The Renal Association UK Renal Registry. The Ninth Annual Report December 2006. http://www.renalreg.com/reports/renal-registry-reports/2006/ [accessed 20 November 2008].
2. Diabetes UK. Impact Report 2006. http://www.diabetes.org.uk/Research/ Publications/Researchmatters/2006/ [accessed 20 November 2008].
3. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219-1222.
4. Blakytny R, Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23: 594-608.
5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 2002; 287: 2570-2581.
6. Wilhelmi M, Haverich A. Materials used for hemodialysis vascular access: current strategies and a call to action. Graft 2003; 6: 6-15.
7. Berardinelli L. Grafts and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg 2006; 32: 203-211.
8. Kannan RY, Salacinski HJ, Butler PE, Hamilton G, Seifalian AM. Current status of prosthetic bypass grafts: a review. J Biomed Mater Res B Appl Biomater 2005; 74: 570-581.
9. Clarke DR, Lust RM, Sun YS, Black KS, Ollerenshaw JD. Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann Thorac Surg 2001; 71: S433-S436.
10. Matsuura JH, Black KS, Levitt AB, Rosenthal D, Wellons ED, Fallon MT et al. Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model. J Am Coll Surg 2004; 198: 778-783.
11. Sidawy A, Gray R, Besarab A, Henry M, Ascher E, Silva M JR et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002; 35: 603-610.
12. Darby CR, Roy D, Deardon D, Cornall A. Depopulated bovine ureteric xenograft for complex haemodialysis vascular access. Eur J Vasc Endovasc Surg 2006; 31: 181-186.
13. Emrecan B, Yilik L, Oz̈bek A, Gurbuz A. Bovine ureter graft for haemodialysis access surgery. Nephrol Dial Transplant 2006; 21: 2290-2291.
14. Warakaulle DR, Evans AL, Cornall AJ, Darby CR, Boardman P, Uberoi R. Diagnostic imaging of and radiologic intervention for bovine ureter grafts used as a novel conduit for hemodialysis fistulas. AJR Am J Roentgenol 2007; 188: 641-646.
15. Bacchini G, Del Vecchio L, Andrulli S, Pontoriero G, Locatelli F. Survival of prosthetic grafts of different materials after impairment of native arteriovenous fistula in hemodialysis patients. ASAIO J 2001; 47: 30-33.
16. Katzman HE, Glickman MH, Schild AF, Fujitani RM, Lawson JH. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 2005; 201: 223-230.
17. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34: 694-700.
18. Polo JR, Ligero JM, Diaz-Cartelle J, Garcia-Pajares R, Cervera T, Reparaz L. Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access. J Vasc Surg 2004; 40: 319-324.
19. Rabkin-Aikawa E, Aikawa M, Farber M, Katz JR, Garcia-Cardena G, Kouchoukos NT et al. Clinical pulmonary autograft valves: pathologic evidence of adaptive remodeling in the aortic site. J Thorac Cardiovasc Surg 2004; 128: 552-561.
20. Akoh JA, Sinha S, Dutta S, Opaluwa AS, Lawson H, Shaw JF et al. A 5-year audit of haemodialysis access. Int J Clin Pract 2005; 59: 847-851.
21. Cull JD, Cull DL, Taylor SM, Carsten CG III, Snyder BA, Youkey JR et al. Prosthetic thigh arteriovenous access: outcome with SVS/AAV reporting standards. J Vasc Surg 2004; 39: 381-386.
22. Matsuura JH, Rosenthal D, Wellons ED, Castronovo CS, Fronk D. Hemodialysis graft infections treated with cryopreserved femoral vein. Cardiovasc Surg 2002; 10: 561-565.
23. Katzman HE, Glickman MH, Schild AF, Fujitani RM, Lawson JH. Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 2005; 201: 223-230.
24. Widmer MK, Aregger F, Stauffer E, Savolainen H, Heller G, Hakki H et al. Intermediate outcome and risk factor assessment of bovine vascular heterografts used as AV-fistulas for hemodialysis access. Eur J Vasc Endovasc Surg 2004; 27: 660-665.